First Horizon Corporation (FHN)

Nov 3, 2026

First Horizon Corporation (NYSE:FHN) has received a consensus "Hold" rating from twenty-one brokerages, with an average 12-month target price of $27.07, compared to its current price of $23.65. The company recently reported quarterly EPS of $0.53, slightly beating estimates, though revenue of $883 million was below expectations. Institutional investors hold a significant portion of the stock, while an executive recently sold a portion of their shares.

Nov 1, 2026

First Horizon Corporation has announced the election of Jeffrey R. Balser, M.D., Ph.D., as an independent director to its Board of Directors and the First Horizon Bank Board of Directors. Dr. Balser is the President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, bringing extensive leadership experience, financial discipline, and community ties to the board. His background in navigating complex regulatory challenges and driving growth at VUMC will be valuable as First Horizon continues to serve its clients and communities.